CD19 binding agents and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9919061
APP PUB NO 20150283255A1
SERIAL NO

14743318

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEAGEN INC21823 30TH DR SE BOTHELL WA 98021

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benjamin, Dennis Redmond, US 25 372
Carter, Paul Mercer Island, US 78 1175
Cerveny, Charles G Seattle, US 13 397
McDonagh, Charlotte Waltham, US 28 779

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00